Background: In 1934, Codman¹ described the clinical picture of adhesive capsulitis with gradual onset of lateral shoulder pain with limitation of active and passive movement. Adhesive capsulitis is a common but poorly understood cause of painful dysfunction of shoulder affecting activities of daily living. Many treatment modalities are available for adhesive capsulitis but there is no definitive evidence of superiority of available procedures one over the other.
Aim: To evaluate functional outcome in adhesive capsulitis of shoulder treated by hydrodilatation and intraarticular steroid injection.
Materials and Methods: A series of 42 patients of adhesive capsulitis between age group 40-70years attended Pgi Swasthiyog Prathisthan, Miraj between June 2020 to June 2022 were included in this study.All patients were treated with hydrodilatation under fluoroscopy with intraarticular steroid injection with subacromial and ac joint injection. All patients were evaluated for functional improvement by oxford shoulder score with a minimum follow up 3 months with a maximum followup of 1 year. Mean age group was 56.66.
Inclusion criteria: All patients with painful restriction of active and passive shoulder mobilization
Exclusion criteria: Post infective shoulder stiffness, rotator cuff tear, previous fracture of proximal humerus, shoulder arthritis.
Results: All patients were assessed by oxford shoulder score pre and post procedure. All patients regained total to near total shoulder movements by end of 1 month.
There was decrease in oxford shoulder score by mean of 20.2 (pre-operative was 32.42 and post-operative was 12.22).
Conclusion: Fluoroscopic hydration with intra-articular steroid injections can be used as a definitive treatment for patients with adhesive capsulitis. This results in significant pain relief and also provides interphase recovery with near-to-full range of motion in the shoulder.